From heart failure to lipid management, our teams bring deep operational experience to complex cardiovascular endpoints and event adjudication.
Solid tumor and hematologic programs supported by specialists fluent in RECIST, biomarker strategy, and adaptive trial design.
Neurodegenerative and CNS trials requiring careful endpoint assessment, rater training, and long-term patient retention.
Autoimmune and inflammatory programs with complex dosing and biomarker-driven patient selection.
Retinal and anterior segment trials with specialized imaging endpoints and site qualification.
Pulmonary programs spanning chronic and acute conditions with spirometry and device-based endpoints.
Diabetes, obesity, and rare metabolic disorders with long-duration endpoints and large enrollment targets.
Vaccine and antimicrobial development with rapid startup capability and adaptive enrollment for outbreak response.
Our scientific teams routinely support rare and emerging indications. Let's discuss your program.
Talk to a specialist